These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28880274)

  • 1. The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition.
    Wang Z; Perez M; Lee ES; Kojima S; Griffin M
    Cell Death Dis; 2017 Sep; 8(9):e3032. PubMed ID: 28880274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis.
    Wang Z; Perez M; Caja S; Melino G; Johnson TS; Lindfors K; Griffin M
    Cell Death Dis; 2013 Sep; 4(9):e808. PubMed ID: 24052076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors.
    Fell S; Wang Z; Blanchard A; Nanthakumar C; Griffin M
    Amino Acids; 2021 Feb; 53(2):205-217. PubMed ID: 33474654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis.
    Beckouche N; Bignon M; Lelarge V; Mathivet T; Pichol-Thievend C; Berndt S; Hardouin J; Garand M; Ardidie-Robouant C; Barret A; Melino G; Lortat-Jacob H; Muller L; Monnot C; Germain S
    Sci Signal; 2015 Jul; 8(385):ra70. PubMed ID: 26175493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.
    Wang Z; Stuckey DJ; Murdoch CE; Camelliti P; Lip GYH; Griffin M
    Cell Death Dis; 2018 Apr; 9(6):613. PubMed ID: 29795262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase 2--a novel inhibitor of adipogenesis.
    Myneni VD; Melino G; Kaartinen MT
    Cell Death Dis; 2015 Aug; 6(8):e1868. PubMed ID: 26313919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFβ1-Induced Transglutaminase-2 Triggers Catabolic Response in Osteoarthritic Chondrocytes by Modulating MMP-13.
    Park JY; Bae HC; Pyo SH; Lee MC; Han HS
    Tissue Eng Regen Med; 2021 Oct; 18(5):831-840. PubMed ID: 34014552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide.
    Telci D; Collighan RJ; Basaga H; Griffin M
    J Biol Chem; 2009 Oct; 284(43):29547-58. PubMed ID: 19657147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
    Ayinde O; Wang Z; Griffin M
    Oncotarget; 2017 Mar; 8(12):20025-20041. PubMed ID: 28223538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P311 induces the transdifferentiation of epidermal stem cells to myofibroblast-like cells by stimulating transforming growth factor β1 expression.
    Li H; Yao Z; He W; Gao H; Bai Y; Yang S; Zhang L; Zhan R; Tan J; Zhou J; Takata M; Wu J; Luo G
    Stem Cell Res Ther; 2016 Dec; 7(1):175. PubMed ID: 27906099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
    Fisher ML; Keillor JW; Xu W; Eckert RL; Kerr C
    Mol Cancer Res; 2015 Jul; 13(7):1083-94. PubMed ID: 25934691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis.
    Nurminsky D; Shanmugasundaram S; Deasey S; Michaud C; Allen S; Hendig D; Dastjerdi A; Francis-West P; Nurminskaya M
    Mech Dev; 2011; 128(3-4):234-45. PubMed ID: 21129482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal and Endothelial Transglutaminase-2 Expression during Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Pearse DD; Otero PA; Diaz A; Pan X; Ghosh M
    Neuroscience; 2021 May; 461():140-154. PubMed ID: 33253822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
    Colak G; Johnson GV
    Neurobiol Dis; 2012 Mar; 45(3):1042-50. PubMed ID: 22198379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic Profiling Reveals the Transglutaminase-2 Externalization Pathway in Kidneys after Unilateral Ureteric Obstruction.
    Furini G; Schroeder N; Huang L; Boocock D; Scarpellini A; Coveney C; Tonoli E; Ramaswamy R; Ball G; Verderio C; Johnson TS; Verderio EAM
    J Am Soc Nephrol; 2018 Mar; 29(3):880-905. PubMed ID: 29382685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase class II α-isoform PI3K-C2α is required for transforming growth factor β-induced Smad signaling in endothelial cells.
    Aki S; Yoshioka K; Okamoto Y; Takuwa N; Takuwa Y
    J Biol Chem; 2015 Mar; 290(10):6086-105. PubMed ID: 25614622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase 2 null macrophages respond to lipopolysaccharide stimulation by elevated proinflammatory cytokine production due to an enhanced αvβ3 integrin-induced Src tyrosine kinase signaling.
    Sarang Z; Köröskényi K; Pallai A; Duró E; Melino G; Griffin M; Fésüs L; Szondy Z
    Immunol Lett; 2011 Jul; 138(1):71-8. PubMed ID: 21420434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth.
    Jones RA; Kotsakis P; Johnson TS; Chau DY; Ali S; Melino G; Griffin M
    Cell Death Differ; 2006 Sep; 13(9):1442-53. PubMed ID: 16294209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis.
    Adamczyk M
    Amino Acids; 2017 Mar; 49(3):625-633. PubMed ID: 27510997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice.
    Tarantino U; Oliva F; Taurisano G; Orlandi A; Pietroni V; Candi E; Melino G; Maffulli N
    Amino Acids; 2009 Apr; 36(4):679-84. PubMed ID: 18594942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.